The First European Legal Event on Biosimilars Launches in December 2019

C5 Communications will host its inaugural Global Legal and Regulatory Summit on Biosimilars in Munich, Germany on the 3-4th December 2019. This is this first and only forum in Europe designed to provide a comprehensive picture of the legal, regulatory and commercial landscape of the biosimilars marketplace in Europe and worldwide.

This exclusive event has been specifically designed for In-House IP Counsel and Directors, Strategists and Business Development Executives, as well as Regulatory Affairs Executives and attorneys operating within the biosimilars community.

Attendees will meet, network and learn from industry heavyweights from Abbott Laboratories, Alexion Pharma GmbH, PolPharma Biologics, Amgen, Biocon Research Limited, Eli Lilly, Fresenius Kabi, U.S. Food and Drug Administration and more!

Obtain Insights from Key Global Industry Stakeholders:

Abbott Laboratories
Alexion Pharma GmbH
Amgen
Biocon Research Limited
Fresenius Kabi
Formycon AG
Glenmark Pharmaceuticals
UCB Biopharma

Benefit from In-Depth Discussions which Will Help You:

Understand how international affairs are influencing the future of biosimilar development and commercialization
Analyse the business and legal repercussions of the EMA and FDA biosimilar approval processes
Comprehend the importance of regulatory exclusivities in biosimilar development from the perspectives of innovators and generics
Assess the effects of the current SPC landscape and manufacturing waiver on biosimilar patents
Navigate the complexities of U.S. market entry: naming, labeling, and marketing considerations
Evaluate the nuances of the Asian Biosimilars marketplace: Japan, Korea, China
Develop innovative strategies to prevent compliance breaches of EU competition law

About C5 Communications

For over 20 years C5 Group companies including American Conference Institute, The Canadian Institute, C5 (UK), have developed and hosted conferences, summits and executive briefings providing the business intelligence that decision makers need, to react decisively and effectively to challenges and opportunities in the marketplace.

With offices in New York, London and Toronto, C5 Group offers hundreds of conferences, forums, and summits each year around the globe. Over 25,000 senior business and public sector executives, lawyers and other professionals from the United States, Europe, Russia and CIS, China, Canada, Australia, Asia and Africa will attend a C5 Group event this year.

Renee C. Quinn Renee C. Quinn is the Chief Operating Officer of IPWatchdog, Inc. Working with IPWatchdog since April of 2006, Renée is a key member of the executive management team, overseeing all [...see more]

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.